Geron | GERN - Sales Revenues

Stock Price
1.29
Daily Change
-0.11 -7.86%
Monthly
-23.67%
Yearly
1.57%
Q2 Forecast
1.26

Geron reported $51.84M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Amgen USD 8.62B 1.28B Mar/2026
Bio Techne USD 311.4M 15.5M Mar/2026
Cytokinetics USD 19.35M 1.59M Mar/2026
Esperion Therapeutics USD 168.45M 81.14M Dec/2025
Exelixis USD 610.8M 12.14M Mar/2026
Genmab DKK 1.06B 36M Dec/2025
Geron USD 51.84M 3.82M Mar/2026
Gilead Sciences USD 7B 930M Mar/2026
Incyte USD 1.27B 240M Mar/2026
MacroGenics USD 20.8M 20.43M Mar/2026
Novartis USD 13.11B 226M Mar/2026
Novavax USD 147.14M 76.69M Dec/2025